AGN acquires MAPP for $25/sh in cash (60% premium): http://finance.yahoo.com/news/allergan-inc-acquire-map-pharmaceuticals-013500252.html The companies were partners on Levadex, an inhaled drug for acute treatment of migraine (#msg-59358620).